Used primarily in pharmaceutical research as a nicotinic acetylcholine receptor (nAChR) ligand, this compound serves as a key intermediate in the synthesis of drugs targeting neurological disorders. It is particularly valuable in the development of agents for cognitive enhancement and the treatment of neurodegenerative conditions such as Alzheimer's disease. Its structural similarity to nicotine allows it to modulate cholinergic transmission, making it useful in studies related to addiction, pain, and mood regulation. Additionally, it is employed in radiolabeled form for receptor binding assays and neuroimaging studies to investigate receptor distribution and density in the brain.